Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Text-to-image AI art generators ...

An Indian pharmaceutical company is manufacturing unlicensed, highly addictive opioids and exporting them illegally to West Africa where they are driving a major public health crisis in countries ...

Image credit: Shutterstock / Tada Images. Figures from across the pharmaceutical and medtech industry have spoken out on social media following the culling of staff at US healthcare agencies, with ...

Dr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest drugmaker, declined by 3.2% to Rs 1,647.35, becoming the top loser on the BSE ...

Trump told reporters on Tuesday that sectoral tariffs on pharmaceuticals and semiconductor chips would also start at "25 per cent or higher, and it will go very substantially higher over the ...

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

President Trump told reporters in Mar-a-lago that he was considering tariffs of 25% or more on automobiles, semiconductors and pharmaceutical products. Photo: Press Pool WASHINGTON—President ...

(Image/Freepik) Donald Trump’s election victory was welcomed by many in India and especially by the Indian pharmaceutical industry. They saw in his return as the US president, elements that ...

Irish exports were valued at a record €223.8 billion last year, with medical and pharmaceutical products contributing heavily to the total. Compared to 2023, the value of exports was up 14% ...

US tariffs on pharmaceutical imports will affect India’s pharma sector, a leader in affordable generics. Analyst Vishal Manchanda highlights risks to Indian firms like Sun Pharma and Cipla due to ...